These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37298347)

  • 1. Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach.
    Alito A; Bellone F; Portaro S; Leonardi G; Cannavò V; Coppini F; Leonetti D; Catalano A; Squadrito G; Fenga D
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and treatment of osteoporosis in patients with hemophilia.
    Lin X; Gao P; Zhang Q; Jiang Y; Wang O; Xia W; Li M
    Arch Osteoporos; 2023 Jan; 18(1):17. PubMed ID: 36598583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures in haemophilia: a systematic review.
    Boehlen F; Graf L; Berntorp E
    Eur J Haematol Suppl; 2014 Aug; 76():2-15. PubMed ID: 24957102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of fractures in patients with haemophilia.
    Caviglia H; Landro ME; Galatro G; Candela M; Neme D
    Injury; 2015 Oct; 46(10):1885-90. PubMed ID: 26190631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The profile of patients with haemophilia managed at a haemophilia treatment centre in Pretoria, Gauteng.
    Mafisa L; Dlova AN; Moodley V
    S Afr Fam Pract (2004); 2022 Oct; 64(1):e1-e7. PubMed ID: 36331203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.
    Iorio A; Königs C; Reding MT; Rotellini D; Skinner MW; Mancuso ME; Berntorp E
    Haemophilia; 2023 Jan; 29(1):33-44. PubMed ID: 36224704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilia: factoring in new therapies.
    Fassel H; McGuinn C
    Br J Haematol; 2021 Sep; 194(5):835-850. PubMed ID: 34322873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer detection and management in patients with haemophilia: a retrospective European multicentre study.
    Biron-Andreani C; de Moerloose P; D'oiron R; Chambost H; Schved JF; Hermans C
    Haemophilia; 2014 Jan; 20(1):78-82. PubMed ID: 23919383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk.
    Anagnostis P; Karras S; Paschou SA; Goulis DG
    Blood Coagul Fibrinolysis; 2015 Sep; 26(6):599-603. PubMed ID: 26126168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilia B: Where are we now and what does the future hold?
    Dolan G; Benson G; Duffy A; Hermans C; Jiménez-Yuste V; Lambert T; Ljung R; Morfini M; Zupančić Šalek S
    Blood Rev; 2018 Jan; 32(1):52-60. PubMed ID: 28826659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registry-based outcome assessment in haemophilia: a scoping study to explore the available evidence.
    Osooli M; Berntorp E
    J Intern Med; 2016 Jun; 279(6):502-14. PubMed ID: 26999367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review.
    Boccalandro EA; Begnozzi V; Garofalo S; Pasca S; Peyvandi F
    Haemophilia; 2023 Jan; 29(1):11-20. PubMed ID: 36167324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective audit of patients with haemophilia: bleeding episodes and management.
    Alexander M; Barnes C; Barnett P
    J Paediatr Child Health; 2012 Feb; 48(2):177-9. PubMed ID: 21564382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.
    Olasupo OO; Lowe MS; Krishan A; Collins P; Iorio A; Matino D
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014201. PubMed ID: 34407214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive management of chronic pain in haemophilia.
    Young G; Tachdjian R; Baumann K; Panopoulos G
    Haemophilia; 2014 Mar; 20(2):e113-20. PubMed ID: 24372731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease prevalence and relevance in haemophilia: a scoping review.
    Rizwan I; Minuk L; Jackson S; Iorio A
    Haemophilia; 2015 May; 21(3):e156-e166. PubMed ID: 25420604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal diseases in haemophilic patients: pathogenesis and clinical management.
    Esposito P; Rampino T; Gregorini M; Fasoli G; Gamba G; Dal Canton A
    Eur J Haematol; 2013 Oct; 91(4):287-94. PubMed ID: 23651176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia.
    Naous E; de Moerloose P; Sleilaty G; Casini A; Djambas Khayat C
    Haemophilia; 2019 Mar; 25(2):264-269. PubMed ID: 30748059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.